We pursue a sustainable growth model by integrating social and environmental aspects into our corporate strategy, mindful that there can be no long-term economic development without responsible action.
We pursue a sustainable growth model by integrating social and environmental aspects into our corporate strategy, mindful that there can be no long-term economic development without responsible action.
We have a long history of entrepreneurial passion and a strong reputation and a desire to continue growing and creating value in an ethical, enduring, and sustainable way, all while respecting the laws and regulations that apply in the countries where we operate, protecting people and the environment, and supplying safe, high-quality products.
100% of electricity purchased for Group plants and annexed offices comes from renewable sources, in countries where this is possible (1)
1st sustainability-linked loan signed the credit facility is linked to two ESG KPIs: environmental protection (renewable energy installed power capacity) and responsible sourcing (ESG audits of suppliers).
More than 14,000 trees planted in the three years 2021-2023, with a commitment to reach 24,000 by 2024, corresponding to approximately 5 trees per employee
Call launched for the 11th Arrigo Recordati Prize international award promoting scientific research into rare diseases
Approximately € 4.8 million in donations to the community (2)
Approximately 1,100 patients affected by rare diseases supported through the Patient Assistance Program, the Co-Pay Assistance Program and similar programmes
Revenue
#THISCUSHING awareness campaign wins award Recordati Rare Diseases received the 2023 PMEA Patient-Centricity Award
1st People Engagement survey completed with an excellent 80% participation rate
2nd D&I survey completed involving approximately 300 Group managers
56% of women hired in 2023 out of total new hires, with the commitment to increase the percentage of women in Top and Senior management positions
94% of employees hired on permanent contracts
115 suppliers audited in the two years 2022-2023 on ESG topics via desk audits conducted by an independent third party
Over 190 supplier audits conducted by the pharmaceutical and chemical-pharmaceutical division, mainly on product quality and safety
This figure excludes Tunisia, where renewable energy is not available. Please refer to the 2023 Consolidated Non Financial Statement for further details.
Including monetary and product donations measured at market value.
INFORMATION ON PERSONAL DATA PROTECTION PURSUANT TO ARTICLE 13 OF LEGISLATIVE DECREE NO. 196/2003
The personal data that you provide by compiling this form will be used by Recordati Industria Chimica e Farmaceutica S.p.A. (“Recordati”) – the “Data Controller” – solely for performing activities connected with the provision of the email alert service and it will be processed manually, by computer and via the internet in a manner that will guarantee its security and confidentiality. It is not compulsory for you to give your data, however, if you refuse to allow it to be processed, then it will be impossible for Recordati to provide you with the above-mentioned service. Your personal data may be passed on to other companies that belong to the RECORDATI Group or to associate companies of the Group and to third parties that Recordati uses to provide the service to you.
In any event we assure you that your data will be processed solely for the above purposes and using the above methods.
The company Tech Style S.r.l. has been appointed as external Data Processor in accordance with Art. 29 of the Privacy Code, because it has been engaged to maintain the technological part of the website. The Director of Investor Relations and Corporate Communication of Recordati S.p.a. has been appointed as internal Data Processor of Recordati in accordance with article 29 of the Privacy Code.
A data subject shall have the right to obtain at any moment confirmation of whether or not data is held on him/her, to know its content and origin, to check its accuracy or to ask for it to be added to, updated or rectified (article 7 of the Privacy Code).
Requests must be sent to the Data Processor of Recordati: by email, to the address: ; or by ordinary mail to Recordati Industria Chimica e Farmaceutica S.p.A. – Director of Investor Relations and Corporate Communications – 1 Via Civitali – 20148 Milan.
In accordance with article 23 of Legislative Decree No. 196/03 on personal data protection, having read the above information, I hereby authorise Recordati S.p.A. to process my personal data for the purposes set out in that same information. I am aware that if I refuse, Recordati will not be able to enable its email alert service for me.
Subsequent withdrawal of consent to the data processing mentioned in the preceding paragraph will result in the cancellation of the subscription request or cancellation of the subscription to the email alert service.